Peripheral adenosine levels in euthymic patients with bipolar disorder

被引:29
作者
Gubert, Carolina [1 ]
Jacintho Moritz, Cesar Eduardo [2 ]
Vasconcelos-Moreno, Mirela Paiva [3 ,4 ]
Martins Quadros dos Santos, Barbara Tietbohl [3 ,4 ]
Sartori, Juliana [3 ,4 ]
Fijtman, Adam [3 ,4 ]
Kauer-Sant'Anna, Marcia [1 ,3 ,4 ,5 ,6 ]
Kapczinski, Flavio [3 ,4 ,5 ,6 ]
Oliveira Battastini, Ana Maria [1 ,2 ]
da Silva Magalhaes, Pedro Vieira [3 ,4 ,5 ,6 ]
机构
[1] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Programa Posgrad Ciencias Biol Bioquim, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Programa Posgrad Med Ciencias Med, BR-90035003 Porto Alegre, RS, Brazil
[3] Hosp Clin Porto Alegre, Bipolar Disorder Program, BR-90035003 Porto Alegre, RS, Brazil
[4] Hosp Clin Porto Alegre, Lab Mol Psychiat, BR-90035003 Porto Alegre, RS, Brazil
[5] Hosp Clin Porto Alegre, INCT Translat Med, BR-90035903 Porto Alegre, RS, Brazil
[6] Univ Fed Rio Grande do Sul, Dept Psiquiatria, Rua Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil
关键词
Bipolar disorder; Adenosine; Psychosocial functioning; Purinergic signaling; Uric acid; URIC-ACID-LEVELS; FUNCTIONAL IMPAIRMENT; MICROGLIAL ACTIVATION; PURINERGIC SYSTEM; RECEPTOR AGONISTS; OXIDATIVE STRESS; XANTHINE-OXIDASE; DIFFERENT PHASES; RATING-SCALE; NITRIC-OXIDE;
D O I
10.1016/j.psychres.2016.10.007
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Recent evidence points to the involvement of the purinergic signaling in the pathophysiology of bipolar disorder. The aim of this study was to assess the serum levels of adenosine and to evaluate its relation to functioning in 24 euthymic patients with bipolar disorder type I and in 25 matched healthy controls. Subjects were evaluated using the functioning assessment short test. Serum purine levels were measured by high pressure liquid chromatography. Our results show a decrease in serum adenosine levels in bipolar disorder patients compared with controls (t= -4.8, df= 43.96, p < 0.001). Moreover, a significant negative correlation was found between patient adenosine levels and depression scale scores (r= -0.642, p= 0.001). Higher functional impairment was linked to lower levels of adenosine in patients (rho= -0.551, p= 0.008). Taken together, our results provide evidence for a purinergic imbalance in bipolar disorder, specifically an adenosinergic dysfunction. Our results also indicate a relation between adenosine levels and the functional impairment caused by the disorder, which could demonstrate a potential relation of adenosine levels in worsening of symptoms.
引用
收藏
页码:421 / 426
页数:6
相关论文
共 62 条
  • [1] Increased uric acid levels in bipolar disorder subjects during different phases of illness
    Albert, Umberto
    De Cori, David
    Aguglia, Andrea
    Barbaro, Francesca
    Bogetto, Filippo
    Maina, Giuseppe
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2015, 173 : 170 - 175
  • [2] [Anonymous], BIPOLAR DISORDER
  • [3] [Anonymous], CELL MOL NEUROBIOL
  • [4] [Anonymous], MOL NEUROBIOL
  • [5] Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
    Berk, M.
    Kapczinski, F.
    Andreazza, A. C.
    Dean, O. M.
    Giorlando, F.
    Maes, M.
    Yuecel, M.
    Gama, C. S.
    Dodd, S.
    Dean, B.
    Magalhaes, P. V. S.
    Amminger, P.
    McGorry, P.
    Malhi, G. S.
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2011, 35 (03) : 804 - 817
  • [6] Adenosine A(1) receptor agonists as clinically viable agents for treatment of ischemic brain disorders
    Bischofberger, N
    Jacobson, KA
    vonLubitz, DKJE
    [J]. NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE, 1997, 825 : 23 - 29
  • [7] Activity of citalopram on adenosine and serotonin circulating levels in depressed patients
    Blardi, P
    de Lalla, A
    Urso, R
    Auteri, A
    Dell'Erba, A
    Bossini, L
    Castrogiovanni, P
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (03) : 262 - 266
  • [8] Adenosine as a neuromodulator in neurological diseases
    Boison, Detlev
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) : 2 - 7
  • [9] Uric Acid as a CNS Antioxidant
    Bowman, Gene L.
    Shannon, Jackilen
    Frei, Balz
    Kaye, Jeffrey A.
    Quinn, Joseph F.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (04) : 1331 - 1336
  • [10] Purinergic signalling and disorders of the central nervous system
    Burnstock, Geoffrey
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (07) : 575 - 590